Intended for use in structural heart procedures, the cardiac imaging catheter is expected to drive growth for Boston Scientific’s Watchman stroke protection device.

East Lansing, Mich.-based Sparrow Health System cardiologists recently performed the 400th successful implant of the Watchman, a device implanted in the upper chamber of the heart to decrease risk of ...

NATICK, Mass., European regulators have approved an expanded indication for the Boston Scientific Corporation WATCHMAN ® Left Atrial Appendage (LAA) Closure Device. The new indication offers patients ...

The Watchman left atrial appendage (LAA) closure device (Boston Scientific) is associated with low 1-year stroke rates, despite being used commercially in older, sicker patients than seen in pivotal ...

Two newly published studies shed light on how real-world patients with atrial fibrillation fared after undergoing left atrial appendage occlusion (LAAO) with the first-generation Watchman device ...

Rock Island, Ill.-based Trinity Heart Center recently implanted its 100th Watchman device, ourquadcities.com reported Feb. 17. In 2020, the center became the first and only healthcare provider in the ...

Cooperstown, N.Y.-based Bassett Medical Center’s interventional cardiology team has completed its 100th Watchman heart procedure. The program originally launched in 2020. The Watchman prevents blood ...

Abbott's Amplatzer Amulet provided superior left atrial appendage (LAA) closure over the old-guard Watchman (Boston Scientific) device but failed to significantly cut stroke or bleeding rates in ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. BOSTON — At 3 years, the Amplatzer Amulet device ...

ABBOTT PARK, Ill., Aug. 30, 2021 /PRNewswire/ -- Abbott (NYSE: ABT) today announced late-breaking data from the Amulet™ LAA Occluder IDE trial, a multi-center, head-to-head study comparing the company ...

Please provide your email address to receive an email when new articles are posted on . The FDA has approved a second-generation left atrial appendage closure device for patients with nonvalvular ...